explore -WSS

explore

author：comprehensive 2025-09-04 22:01:03 - browse：366

Is Wegovy the future of cardiology? Can Novo Nordisk ever make enough of it? And will there ever be an Apple of pharma?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. In the wake of a massively important clinical trial of Novo Nordisk’s obesity drug Wegovy, our colleague Elaine Chen joins us to explain what we know and don’t know about data that could change the practice of medicine. Then, Mizuho Securities biotech strategist Jared Holz calls in to discuss whether explosive popularity of obesity treatments could help create the first trillion-dollar drug company.

For more on what we cover, here’s the news on the Wegovy study; here’s more on its implications; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： How one medical school became remarkably diverse

entertainment

WSS

How to improve immunocompromised access to mAb treatments

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Guidelines to prevent youth baseball injuries need more muscle

Medical records are filled with copy

As demand for Covid shots wanes, Moderna seeks its next success

entertainment

explore

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

How to improve immunocompromised access to mAb treatments

Drug repurposing or repositioning? The language matters

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Medical records are filled with copy

How one medical school became remarkably diverse

DIEP, the 'gold standard' of breast reconstruction, is under threat

Making AI in medicine accessible to smaller, and rural hospitals

In age of alternative facts, a scholarly course on calling out crap

After affirmative action ruling, medical educators look to 'holistic review'

focus

How to improve immunocompromised access to mAb treatments

After affirmative action ruling, medical educators look to 'holistic review'

State Dept. review finds Biden bears some blame for Afghanistan failures

What does generative AI mean for health care? We asked experts

Continuity nursing helped my family in our darkest PICU moments

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Wikipedia

Wikipedia

entertainment

focus